Table 1 Preoperative background characteristics of the patients BCVA, best corrected visual acuity. CMT central macular thickness, MA-PC photocoagulation for microaneurysm, PPV pars plana vitrectomy, SD standard deviation, STTA sub-Tenon triamcinolone acetonide administration, VEGF vascular endothelial growth factors.
Total | Recurrence group | No recurrence group | p-value | |
|---|---|---|---|---|
Number of patients | 31 | 12 | 19 | |
Sex (male, female) | 16, 11 | 7, 4 | 9, 8 | 0.87 |
Age, average ± SD (years) | 67.2 ± 9.3 | 64.2 ± 10.1 | 69.0 ± 8.5 | 0.09 |
Lens status, phakia/pseudophakia (eyes) | 6, 25 | 4, 8 | 2, 17 | 0.17 |
Pre BCVA, average ± SD (logMAR) | 0.41 ± 0.29 | 0.41 ± 0.29 | 0.38 ± 0.27 | 0.85 |
Pre CMT, average ± SD (µm) | 514.2 ± 132.9 | 514.2 ± 132.9 | 510.4 ± 121.2 | 0.33 |
Fibrinogen clot removal (yes/no) | 14/17 | 5/7 | 9/10 | 0.95 |
Number of total treatments in the year before surgery (average ± SD) | 3.5 ± 2.5 | 3.7 ± 1.9 | 3.3 ± 2.8 | 0.35 |
Anti-VEGF therapy | 1.7 ± 2.3 | 1.8 ± 1.9 | 1.7 ± 2.6 | 0.87 |
STTA | 0.4 ± 0.7 | 0.5 ± 0.8 | 0.4 ± 0.6 | 0.10 |
MA-PC | 0.8 ± 0.4 | 0.9 ± 0.3 | 0.7 ± 0.5 | 0.38 |
PPV | 0.5 ± 0.5 | 0.5 ± 0.5 | 0.5 ± 0.5 | 0.89 |
Number of visits in the year before surgery (average ± SD) | 14.5 ± 6.6 | 14.9 ± 7.2 | 14.3 ± 6.4 | 0.34 |
